- Home
- Home
- "Laboratory Workers"
- "Physicians"
- "Safety"
- Registration projects in health and health care
Scope
- Safety Remove Safety filter
- Epidemiology (2) Apply Epidemiology filter
- Diagnosis (1) Apply Diagnosis filter
- Efficacy (1) Apply Efficacy filter
- Pharmacoeconomic (1) Apply Pharmacoeconomic filter
- Pharmacogenetic (1) Apply Pharmacogenetic filter
- Pharmacogenomic (1) Apply Pharmacogenomic filter
- Pharmacovigilance (1) Apply Pharmacovigilance filter
- Public Administration (1) Apply Public Administration filter
- Quality of care research (1) Apply Quality of care research filter
- Therapy (1) Apply Therapy filter
Commissioners
- Andrew Cunningham (1) Apply Andrew Cunningham filter
- Anouk Waeytens (1) Apply Anouk Waeytens filter
- European Monitoring Centre for Drugs and Drug Addiction (1) Apply European Monitoring Centre for Drugs and Drug Addiction filter
- Interministerial Conference of Public Health (1) Apply Interministerial Conference of Public Health filter
- Kurt Doms (1) Apply Kurt Doms filter
- National Institute for Health and Disability Insurance (1) Apply National Institute for Health and Disability Insurance filter
Careprovider
- Laboratories: clinical biology (2) Apply Laboratories: clinical biology filter
- General hospitals (1) Apply General hospitals filter
- Laboratories: anatomical pathology (1) Apply Laboratories: anatomical pathology filter
- Laboratories: human genetics (1) Apply Laboratories: human genetics filter
- Psychiatric hospitals (1) Apply Psychiatric hospitals filter
Caregiver
Sponsors
Support
- National Institute for Health and Disability Insurance (2) Apply National Institute for Health and Disability Insurance filter
- Federal Public Service Health, Food Chain Safety and Environment - cell quality and patient safety (1) Apply Federal Public Service Health, Food Chain Safety and Environment - cell quality and patient safety filter
Registration projects in health and health care
The BEWSD database collects information regarding the analysis of illicit drug samples (both known illicit drugs and new psychoactive substances) in Belgium.This concerns mostly analytical data regarding dosage/purity/contaminants of seized powders, tablets, etc. In the future, also clinical toxicological data will be added, describing intoxications with known illicit drugs or new psychoactive substances, originating from the clinical toxicology laboratories in Belgium.
For a number of diseases/disorders, personalized treatment today offers a great added value compared to classical, empirical therapy. Thanks to molecular diagnostics, specific aberrations can be detected, which are an indication for a correct diagnosis and prognosis and the successful use of a corresponding drug in order to target the disease.
Currently the reimbursement of personalized medicines is not coupled with that of the accompanying biomarker which often leads to a delay in reimbursement of the predictive tests as compared to the personalized medicine. To better align...